ArticleBiology open2020

An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.

Zi-Yan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.